There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To compare the abilities and associated hypoglycemia risks of insulin glargine and
human NPH insulin added to oral therapy of type 2 diabetes to achieve 7% HbA(1c).